MYC-targeting by OMO-103 in solid tumours: a phase 1 trial
收藏NIAID Data Ecosystem2026-05-01 收录
数据链接：
官方服务：
资源简介：
A Phase I Dose-Escalation Study of a first-in-modality MYC inhibitor, OMO-103, in All-Comers Solid Tumors and identification of potential biomarkers
创建时间：
2024-02-07
